Connect with us

World News

In AI-enabled drug discovery, there might be more than one winner on July 29, 2023 at 5:00 pm

Published

on

W
elcome to the TechCrunch Exchange, a weekly startups-and-markets newsletter. It’s inspired by the daily TechCrunch+ column where it gets its name. Want it in your inbox every Saturday? Sign up here.

Today, a look at Israel from three different angles: drug discovery, AI-enabled cybersecurity threats, and investor reactions to the political crisis. — Anna

From spatial biology to proteomics

Chipmaker Nvidia invested $50 million into biotech startup Recursion, which now plans to “accelerate [the] development of its AI foundation models for biology and chemistry,” according to a press release.

Advertisement

Recursion CTO Ben Mabey said the company aims to build “a definitive foundation model for the drug discovery space.” That’s no easy feat; its CEO Chris Gibson referred to drug discovery as “one of the world’s most difficult challenges.”

However, both Recursion and Nvidia hope AI can help solve this challenge. “Generative AI is a revolutionary tool to discover new medicines and treatments,” Nvidia CEO Jensen Huang wrote in a canned statement.

Recursion is far from the only company working on this; in May, it acquired two companies in the AI-enabled drug discovery space, Cyclica and Valence. But while these three companies are headquartered in North America, I couldn’t help but notice that a number of their competitors are based in Israel.

I asked Lior Handelsman and Renana Ashkenazi, two general partners at Israeli VC firm Grove Ventures, why Israel may be an AI-enabled biotech hotbed. They mentioned some factors I was expecting, such as academic talent and the entrepreneurial spirit that already turned the country into a Startup Nation. But Ashkenazi also noted that the profile of biotech founders is changing.

Advertisement

​ It’s encouraging to think that multiple startups will find ways to leverage AI and other fields to accelerate drug discovery and improve patient outcome. 

Advertisement
Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

World News

Niremia Collective closes inaugural fund with $22.5M focused on well-being technology on February 2, 2024 at 1:59 pm

Published

on

By

Niremia Collective intends to provide capital and management resources to high-growth well-being startups as well as incubate new businesses.

© 2024 TechCrunch. All rights reserved. For personal use only.

​ [[{“value”:”Niremia Collective intends to provide capital and management resources to high-growth well-being startups as well as incubate new businesses.
© 2024 TechCrunch. All rights reserved. For personal use only.”}]] 

Advertisement

Continue Reading

World News

FTC orders Blackbaud to overhaul ‘reckless’ security practices in wake of 2020 breach on February 2, 2024 at 1:20 pm

Published

on

By

Education tech company Blackbaud agreed to settle with the U.S. Federal Trade Commission over the company’s security practices that resulted in a 2020 data breach. The FTC alleges that Blackbaud, a U.S.-based company that provides financial and administrative software to colleges, nonprofits, healthcare organizations, and far-right organizations, had “lax” security protocols that allowed attackers to […]

© 2024 TechCrunch. All rights reserved. For personal use only.

​ [[{“value”:”Education tech company Blackbaud agreed to settle with the U.S. Federal Trade Commission over the company’s security practices that resulted in a 2020 data breach. The FTC alleges that Blackbaud, a U.S.-based company that provides financial and administrative software to colleges, nonprofits, healthcare organizations, and far-right organizations, had “lax” security protocols that allowed attackers to
© 2024 TechCrunch. All rights reserved. For personal use only.”}]] 

Advertisement

Continue Reading

World News

Apple says it’ll show its GenAI efforts ‘later this year’ on February 2, 2024 at 12:14 pm

Published

on

By

Apple has tossed another crumb to investors wondering when the world will get to see some ‘Made in Cupertino’ GenAI: Expect Apple to reveal what it’s been working on in this buzzy slice of artificial intelligence “later this year”, per CEO Tim Cook. During an earnings call yesterday, Apple’s chief exec emphasized its ongoing investment […]

© 2024 TechCrunch. All rights reserved. For personal use only.

​ [[{“value”:”Apple has tossed another crumb to investors wondering when the world will get to see some ‘Made in Cupertino’ GenAI: Expect Apple to reveal what it’s been working on in this buzzy slice of artificial intelligence “later this year”, per CEO Tim Cook. During an earnings call yesterday, Apple’s chief exec emphasized its ongoing investment
© 2024 TechCrunch. All rights reserved. For personal use only.”}]] 

Advertisement

Continue Reading

Trending

0
    0
    Your Cart
    Your cart is emptyReturn to Shop